International Association for the Study of Lung Cancer ( IASLC)

Primary tabs

IASLC's picture

Management

Contact Address

About International Association for the Study of Lung Cancer

The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated to the study of lung cancer. Founded in 1974, the association's membership includes more than 4,000 lung cancer specialists in over 90 countries.

IASLC press release, blog etc

Wed, 08/14/2024 - 08:27 International Lung Cancer Experts Seek Public Comments on Updated Molecular Testing Guideline to Improve Patient Selection and Targeted Therapies
Mon, 08/05/2024 - 13:27 Insufficient Evidence to Recommend Low-Dose CT Screening in Never Smokers Lung Cancer Screening: New Insights and Ongoing Debates
Thu, 06/27/2024 - 14:15 Journal of Thoracic Oncology 2023 Impact Factor Increases Over Rating in 2022; JTO Clinical and Research Reports Off to a Strong Start
Mon, 11/14/2022 - 16:21 IASLC Names Four Multidisciplinary International Doctors as Co-Chairs of IASLC 2024 World Conference on Lung Cancer
Tue, 11/01/2022 - 10:37 IASLC Position Statement on Tobacco Cessation After a Cancer Diagnosis
Mon, 10/03/2022 - 11:01 Expanding LDCT Eligibility Guidelines Would Increase Number of Women and Blacks Who Benefit from Screening
Sun, 08/07/2022 - 13:12 NELSON Trial Protocol More Sensitive than NLST and May Increase the Benefits of Lung Cancer Screening, While Reducing Unnecessary Follow-up Procedures
Sun, 08/07/2022 - 12:43 Tumor Bulk-RNA Seq Identifies Patients at High Risk of Progression in Non-Complete Pathological Responders from NADIM Trial
Sun, 08/07/2022 - 10:56 Increased Utilization of Stereotactic Body Radiotherapy Has Decreased Treatment Disparities for Early-Stage NSCLC
Sun, 08/07/2022 - 10:24 Budget Impact Analysis Demonstrates NELSON Screening Model Would Save More Than 18,000 Premature Lung Cancer Deaths
Sun, 08/07/2022 - 10:21 Study Finds Second Primary Lung Cancer is 4 Percent and as High as 8 Percent Among Surgery Patients
Wed, 06/22/2022 - 15:58 COVID-19 vaccines safe for patients treated for lung cancer with immune checkpoint inhibitors
Tue, 01/04/2022 - 05:00 Smoking Cessation after Cancer Diagnosis Associated with Improved Survivial
Mon, 12/20/2021 - 03:30 Karen L. Kelly, MD named Chief Executive Officer of the International Association for the Study of Lung Cancer
Tue, 11/16/2021 - 05:51 COVID-19 Vaccine Effective in Patients with Lung Cancer Results from a French study published in the Journal of Thoracic Oncology
Thu, 10/28/2021 - 03:43 Global Lung Cancer Awareness Month Coalition Launches to Transform Survival
Tue, 10/12/2021 - 03:32 IASLC Announces that JTO Clinical and Research Reports Articles are Now Available on PubMed
Mon, 09/13/2021 - 06:04 Pre-treatment Levels of ctDNA May Be Useful in Future Clinical Trials to Predict Long-Term Survival

InfoBox

HomePagewww.iaslc.org